R&D expense of selected Chinese pharma companies 2022
In 2022, the research and development expenses of Yiling Pharmaceutical amounted to almost 900 million yuan, ranked in the first three compared to peer companies. Overall, only two pharmaceutical companies spent more than one billion yuan on research and development.